Company profile for Calithera Biosciences

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Calithera is a clinical-stage biopharmaceutical company pioneering the discovery and development of targeted, small molecule therapies that disrupt cellular metabolic pathways to preferentially block tumor cell growth and enhance immune-cell activity. Tumor metabolism and tumor immunology are promising new interrelated fields for cancer drug discovery. They offer the potential for fundamentally new therapies for people with ca...
Calithera is a clinical-stage biopharmaceutical company pioneering the discovery and development of targeted, small molecule therapies that disrupt cellular metabolic pathways to preferentially block tumor cell growth and enhance immune-cell activity. Tumor metabolism and tumor immunology are promising new interrelated fields for cancer drug discovery. They offer the potential for fundamentally new therapies for people with cancer and other life-threatening diseases. Calithera’s pipeline consisting of multiple, novel compounds targets key metabolic enzymes to disrupt metabolic pathways that provide tumor and other diseased cells.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
343 Oyster Point Blvd, Suite 200 South San Francisco, CA 94080
Telephone
Telephone
+1 650 870 1000
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2023/06/29/2697420/32478/en/Calithera-Biosciences-Announces-Update-on-Complete-Liquidation-and-Dissolution.html

GLOBENEWSWIRE
29 Jun 2023

https://www.globenewswire.com/news-release/2023/05/19/2672782/32478/en/Calithera-Biosciences-Announces-Update-on-Complete-Liquidation-and-Dissolution.html

GLOBENEWSWIRE
19 May 2023

https://www.globenewswire.com/news-release/2023/01/09/2585158/32478/en/Calithera-Biosciences-Announces-Board-Approval-of-Complete-Liquidation-and-Dissolution.html

GLOBENEWSWIRE
09 Jan 2023

https://endpts.com/calithera-to-shut-down-after-failing-to-revive-takeda-assets/

ENDPTS
09 Jan 2023

https://www.globenewswire.com/news-release/2022/11/14/2555452/32478/en/Calithera-Biosciences-Reports-Third-Quarter-2022-Financial-Results-and-Business-Update.html

GLOBENEWSWIRE
14 Nov 2022

https://www.globenewswire.com/news-release/2022/11/08/2551507/32478/en/Calithera-Biosciences-to-Report-Third-Quarter-2022-Financial-Results-on-Monday-November-14-2022.html

GLOBENEWSWIRE
08 Nov 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty